FDA Guidance On ANDA Antibundling Statute Expected In February

The ANDA bundling and antibundling provisions of the Medicare law will be part of a "short guidance" that FDA expects to issue in February

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet